This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB06870/identifier/pdb/
n12http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB06870/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB06870/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB06870/identifier/drugbank/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB06870/identifier/chemspider/

Statements

Subject Item
n2:DB06870
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB06870 n12:DB06870
dcterms:title
17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE
adms:identifier
n8:6857686 n9:99443341 n10:DB06870 n11:17H n13:5257020
n3:IUPAC-Name
n4:271B59E3-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B59E9-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B59E8-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B59E5-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B59E6-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B59E7-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B59E1-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B59E2-363D-11E5-9242-09173F13E4C5 n4:271B59DF-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B59E0-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B59EF-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B59F0-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B59EA-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B59EB-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B59ED-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B59EC-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B59EE-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B59F5-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B59F7-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B59F8-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B59F4-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B59F3-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B59F6-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B59E4-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B59F1-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B59F2-363D-11E5-9242-09173F13E4C5